久久偷看各类wc女厕嘘嘘偷窃,国语对白农村老太婆bbw,久久婷婷五月综合色欧美,久久人与动人物a级毛片,久久久亚洲欧洲日产国码是av

BD OptiBuild? RY586 Mouse Anti-Human Neuropilin-1 (CD304) 流式抗體



商城價: 登錄可見

品    牌:BD Biosciences

貨    號:753267

規(guī)    格:

運(yùn)費(fèi): 登錄后可查看運(yùn)費(fèi)

DeepBio得分:
DeepBio得分 是基于文獻(xiàn)引用次數(shù),影響因子,文獻(xiàn)新近度等因素計算的客觀產(chǎn)品評級,得分越高表明該產(chǎn)品經(jīng)過越可靠的實(shí)驗(yàn)驗(yàn)證,質(zhì)量可信度越高
2家供應(yīng)商在售
商品名稱 規(guī)格 代理級別 價格 運(yùn)費(fèi) 供應(yīng)商 購買
BD OptiBuild? RY586 Mouse Anti-Human Neuropilin-1 (CD304) 流式抗體
交貨周期:30
50 μg 經(jīng)銷
登錄可見

-

深圳市安迪康生物科技有限公司
庫存:1
BD OptiBuild? RY586 Mouse Anti-Human Neuropilin-1 (CD304) 流式抗體
交貨周期:30
50 μg 經(jīng)銷
登錄可見

-

廣州鋆泰生物科技有限公司
庫存:88

  • 產(chǎn)品詳情

Alternative Name:Neuropilin; NRP; NP1; Blood dendritic cell antigen 4; BDCA-4; VEGF165R|Application:Flow cytometry (Qualified)|Brand:BD OptiBuild?|Concentration:0.2 mg/ml|Immunogen:Recombinant Human Neuropilin-1|Isotype:Mouse IgG2b, κ|Reactivity:Human (Tested in Development)|Regulatory Status:RUO|Storage Buffer:Aqueous buffered solution containing ≤0.09% sodium azide.|描述: The U21-1283 monoclonal antibody specifically recognizes Neuropilin-1 (NRP1), also known as CD304, Blood dendritic cell antigen 4 (BDCA4), and Vascular endothelial cell growth factor 165 receptor (VEGF165R). CD304 is a type I transmembrane glycoprotein involved in the development of the nervous and cardiovascular systems. It mediates the interaction, growth, survival, and migration of a variety of normal and tumor cells. CD304 is expressed on neurons, thymocytes, regulatory T cells, a subset of T follicular helper cells, dendritic cells, endothelial cells, and certain tumor cells. Neuropilin-1 has a very short cytoplasmic domain and interacts with various coreceptors to form ligand-binding, signal-transducing receptor complexes. CD304 complexes with Plexin-A family members to bind chemorepellent Class 3 Semaphorins and guide neuronal axon growth. It also functions as a coreceptor with VEGFR2/CD309 to stimulate angiogenesis in response to VEGF165. CD304 mediates the interactions between some T cells and dendritic cells. |商品通知:Researchers should determine the optimal concentration of this reagent for their individual applications.The production process underwent stringent testing and validation to assure that it generates a high-quality conjugate with consistent performance and specific binding activity. However, verification testing has not been performed on all conjugate lots.An isotype control should be used at the same concentration as the antibody of interest.Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.CF? is a trademark of Biotium, Inc.For fluorochrome spectra and suitable instrument settings, please refer to our Multicolor Flow Cytometry web page Since applications vary, each investigator should titrate the reagent to obtain optimal results.Human donor specific background has been observed in relation to the presence of anti-polyethylene glycol (PEG) antibodies, developed as a result of certain vaccines containing PEG, including some COVID-19 vaccines. We recommend use of BD Horizon Brilliant? Stain Buffer in your experiments to help mitigate potential background. |推薦的實(shí)驗(yàn)流程: BD? CompBeads can be used as surrogates to assess fluorescence spillover (compensation). When fluorochrome conjugated antibodies are bound to BD? CompBeads, they have spectral properties very similar to cells. However, for some fluorochromes there can be small differences in spectral emissions compared to cells, resulting in spillover values that differ when compared to biological controls. It is strongly recommended that when using a reagent for the first time, users compare the spillover on cells and BD? CompBeads to ensure that BD? CompBeads are appropriate for your specific cellular application.

友情鏈接 :  中國科學(xué)院 國科控股 喀斯瑪控股有限公司 中科海外人才創(chuàng)業(yè)園

商城介紹 | 媒體報道 | 法規(guī)政策 | 協(xié)議專區(qū)

京公網(wǎng)安備 11010802025067號 增值電信業(yè)務(wù)經(jīng)營許可證:京B2-20171454 ICP備案號:京ICP備16050672號-1 喀斯瑪科技版權(quán)所有 2017-

藥品醫(yī)療器械網(wǎng)絡(luò)信息服務(wù)備案: (京)-網(wǎng)藥械信息備字(2022)第00393號 醫(yī)療器械網(wǎng)絡(luò)交易服務(wù)第三方平臺備案編號:京網(wǎng)械平臺備字(2021)第00006號

網(wǎng)絡(luò)食品交易第三方平臺提供者備案 :京食藥網(wǎng)食備202110062 信息系統(tǒng)安全等級保護(hù)備案證明(三級)